Retrospective Cohort Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Apr 7, 2016; 22(13): 3602-3610
Published online Apr 7, 2016. doi: 10.3748/wjg.v22.i13.3602
Table 3 Pathologic evaluation n (%)
L-TMER-TMEP value
(n = 58)(n = 53)
TNM stage0.716
Stage I28 (48.3)22 (41.5)
Stage II11 (19.0)8 (15.1)
Stage III13 (22.4)18 (34.0)
Pathological complete response6 (10.3)5 (9.4)0.381
Total harvested lymph nodes111 (3-27)18 (4-49)< 0.001
DRM1 (cm)1.5 (0.5-5)2.5 (0.5-10)< 0.001
DRM0.729
Involved1 (1.7)1 (1.9)
Non involved57 (98.3)52 (98.1)
CRM0.523
Involved1 (1.7)0
Non involved57 (98.3)53 (100)
Lymphovascular invasion10 (17.2)5 (9.4)0.087